The Trump administration has taken steps to strengthen domestic manufacturing across all industries since coming into office ...

DTC prescription drug models are reshaping the pharma industry by altering pricing dynamics and enhancing patient access, ...

Lilly’s first Phase III results for retatrutide show unprecedented weight loss and marked reductions in osteoarthritis pain, ...

OTR Therapeutics and Zealand Pharma collaborate to develop novel metabolic disease treatments, with a potential deal value of ...

PE: How will recent regulatory developments at FDA impact feasibility assessments in clinical planning? Woollett: It’s ...

In today’s Pharmaceutical Executive Daily, the FDA introduces a new superiority standard for future CAR-T approvals, Relation ...

While pharmaceutical pricing has been a controversial topic for many years, a new spotlight was shone on it over the past 12 months.